Exchange proteins directly activated by cAMP (EPAC1 and EPAC2) are important allosteric regulators of cAMP-mediated signal transduction pathways. To understand the molecular mechanism of EPAC activation, we performed detailed Small-Angle X-ray Scattering (SAXS) analysis of EPAC1 in its apo (inactive), cAMP-bound, and effector (Rap1b)-bound states. Our study demonstrates that we can model the solution structures of EPAC1 in each state using ensemble analysis and homology models derived from the crystal structures of EPAC2. The N-terminal domain of EPAC1, which is not conserved between EPAC1 and EPAC2, appears folded and interacts specifically with another component of EPAC1 in each state. The apo-EPAC1 state is a dynamic mixture of a compact (Rg = 32.9 Å, 86%) and a more extended (Rg = 38.5 Å, 13%) conformation. The cAMP-bound form of EPAC1 in the absence of Rap1 forms a dimer in solution; but its molecular structure is still compatible with the active EPAC1 conformation of the ternary complex model with cAMP and Rap1. Herein, we show that SAXS can elucidate the conformational states of EPAC1 activation as it proceeds from the compact, inactive apo conformation through a previously unknown intermediate-state, to the extended cAMP-bound form, and then binds to its effector (Rap1b) in a ternary complex.Cells 2020, 9, 35 2 of 18 due to their distinct tissue and cellular distributions and abilities to form discrete signalosomes through interaction with specific cellular partners [4]. In fact, the N-terminal sequence variation between EPAC1 and EPAC2 plays an important role in their functional diversities. For example, the CNBD-A of EPAC2, while very poor at binding cAMP, is critical for directing EPAC2 to the granule sites in β-cells [5]. Removal of the CNBD-A in EPAC2 alters the cellular localization of EPAC2 from the proximity of plasma membrane to the cytoplasm [6]. On the other hand, the N-terminal domain (NTD) of EPAC1 contains a mitochondrial targeting motif and is important for mitochondrial localization [7], as well as interaction with the ezrin-radixin-moesin (ERM) family of scaffolding proteins [8].Since their discovery, EPAC proteins have been found to be involved in an extensive and growing number of signaling pathways [9,10]. A multitude of recent in vivo studies based on targeted gene knockout mouse models have further revealed the physiological roles of EPACs in learning and social interactions [10], cardiovascular responses [11][12][13][14], pain sensitivity in sensory neurons [15,16], as well as cellular metabolism, including glucose and lipid homeostasis [11,[17][18][19][20][21][22]. These studies indicate that EPAC proteins may play an important role in the development of major diseases ranging from autism, cancer, chronic pain, and heart failure to the growing modern epidemics of obesity and diabetes [4]. Crystal structures of the Murine apo-EPAC2, the mutant apo-EPAC2-F435G, and the truncated ternary EPAC2: cAMP: Rap1b complex have been determined [23][24][25]. These structures have aided our unde...